For instance, CD133 and CD44 molecules have been successfully used to identify lung cancer cells with CSC properties in some studies15,16, whereas other publications reported that CD133− or CD44− cell populations also possess the ability for self-renewal and enhanced tumor initiation capacity when transplanted into mice17,18. This evidence concerns the gene CD44 and lung cancer.